FINAL-Androgens-in-Men-Standalone

Recommendations

Info

Authors: Shalender Bhasin, Glenn R. Cunningham, Frances J. Hayes, Alvin M. Matsumoto, Peter J. Snyder, Ronald S. Swerdloff, and Victor M. Montori Affiliations: Boston University School of Medicine (S.B.), Boston, Massachusetts; Baylor College of Medicine/ Veterans Affairs Medical Center (G.R.C.), Houston, Texas; St. Vincent’s University Hospital (F.J.H.), Dublin, Ireland; University of Washington/Veterans Affairs Puget Sound Health Care System (A.M.M.), Seattle, Washington; University of Pennsylvania School of Medicine (P.J.S.), Philadelphia, Pennsylvania; Harbor University of California, Los Angeles Medical Center (R.S.S.), Torrance, California; and Mayo Clinic (V.M.M.), Rochester, Minnesota. Disclaimer: Clinical Practice Guidelines are developed to be of assistance to endocrinologists and other health care professionals by providing guidance and recommendations for particular areas of practice. The Guidelines should not be considered inclusive of all proper approaches or methods, or exclusive of others. The Guidelines cannot guarantee any specific outcome, nor do they establish a standard of care. The Guidelines are not intended to dictate the treatment of a particular patient. Treatment decisions must be made based on the independent judgment of health care providers and each patient’s individual circumstances. The Endocrine Society makes no warranty, express or implied, regarding the Guidelines and specifically excludes any warranties of merchantability and fitness for a particular use or purpose. The Society shall not be liable for direct, indirect, special, incidental, or consequential damages related to the use of the information contained herein. First published in Journal of Clinical Endocrinology & Metabolism, June 2010, Vol. 95(6):2536–2559. This revised guideline replaces the previous version published in 2006: Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori, VM 2006 Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline (J Clin Endocrinol Metab 91:1995– 2101l doi: 10.1210/jc.2005–2847) This guideline is also available with CME. Go to http://www.endo-society.org/guidelines/Current-Clinical-Practice-Guidelines.cfm for more details. © The Endocrine Society, 2010
T h e E n d o c r i n e S o c i e t y ’ s Clinical Guidelines Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
Page 1: T h e E n d o c r i n e S o c i e t
Page 5 and 6: Abstract Objective: To update the g
Page 7 and 8: We recommend against testosterone t
Page 9 and 10: 1.0. DIAGNOSIS OF HYPOGONADISM Defi
Page 11 and 12: measurement for the diagnosis of an
Page 13 and 14: FIG. 1. An approach for the diagnos
Page 15 and 16: it. no clinical trials have assesse
Page 17 and 18: men with obesity (65, 66) or type 2
Page 19 and 20: Most studies of testosterone therap
Page 21 and 22: TABLE 7. Some recommended regimens*
Page 23 and 24: of subjects experienced an improvem
Page 25 and 26: Adverse outcomes associated with te
Page 27 and 28: References 1. Atkins D, Best D, Bri
Page 29 and 30: 55. Brodsky IG, Balagopal P, Nair K
Page 31 and 32: 105. Bretton PR 1994 Prostate-speci
Page 33 and 34: Acknowledgments The members of the
Page 35 and 36: Commercial Reprint Information For

FINAL-Androgens-in-Men-Standalone

Create successful ePaper yourself

Delete template?

Save as template?